1. Home
  2. CDIO

as of 04-09-2026 9:39am EST

$1.96
$0.07
-3.45%
Stocks Health Care Biotechnology: Commercial Physical & Biological Resarch Nasdaq

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.

Founded: 2017 Country:
United States
United States
Employees: 17 City: CHICAGO
Market Cap: 6.0M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 262.6K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $0.18 - $7.91 Next Earning Date: 05-14-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 171906.75% Revenue Growth (next year): N/A
P/E Ratio: N/A Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

AI-Powered CDIO Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 14 hours ago

AI Recommendation

hold
Model Accuracy: 74.83%
74.83%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: